Kleiner Perkins announces a $2 billion capital increase, proving that established firms are still capable of raising large sums October 3, 2024 Read More
Exsilio Therapeutics launches with $82 million Series A Financing for the Development of Redosable Genomic Medicines to Treat a Broad Range Of Diseases October 3, 2024 Read More
